NL-OMON29135
Recruiting
Not Applicable
Antibody response to pneumococcal vaccination in patients with inflammatory bowel disease patients treated with immunosuppressive agents - the PNEUMOREACT study
Academic Medical Center0 sites188 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- inflammatory bowel disease (inflammatoire darmziekte)immunosuppressive agents (immunosuppressiva)pneumococcal vaccination (pneumokokkenvaccinatie)vaccine immunogenicity (vaccin immunogeniciteit)
- Sponsor
- Academic Medical Center
- Enrollment
- 188
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \> 18 years old
- •On treatment with an immunosuppressive agent or planned treatment start with a TNF\-alpha inhibitor within 3 months after recruitment
Exclusion Criteria
- •Diagnosis of a primary immune deficiency disorder
- •Age \< 18 years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
The antibody response to pneumococcal vaccination in patients with inflammatory bowel disease patients treated with immunosuppressive agentsantibody responseprotection after vaccination1001796910027665NL-OMON45696Academisch Medisch Centrum178
Active, not recruiting
Phase 1
Immune response test as new predictor for successful TKI stop in patients with chronic myeloid leukemiaChronic myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10009016Term: Chronic myeloid leukemia in remissionSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10009015Term: Chronic myeloid leukemiaSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2020-002850-26-NLAlbert Schweitzer Hospital57
Recruiting
Not Applicable
Vaccination response to pneumococcal antigen as novel predictor for successful tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.NL-OMON55091Albert Schweitzer Ziekenhuis57
Active, not recruiting
Not Applicable
Immune response to pneumococcal conjugate vaccine in adults receiving hepatitis A vaccine concomitantly18 years old or older volunteers with general good healthEUCTR2012-003484-22-FIHelsinki University Central Hospital600
Active, not recruiting
Not Applicable
Immune response to pneumococcal conjugate vaccine in adults receiving hepatitis A vaccine concomitantlyEUCTR2012-003484-22-SEHelsinki University Central Hospital300